Comorbidity in psychiatry: its impact on psychopharmacological treatment.
The existence of two or more diagnoses (psychiatric, or a combination with somatic) in one person leads to a dilemma when choosing psychopharmacs for the treatment of the patient. There are no acceptable and comprehensive guidelines or algorithms for the treatment of innumerable possible combinations of psychiatric and somatic disorders. A strategy for treatment of such conditions is needed.
Academy of sciences and Arts of Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina. sloga@tel.net.ba
Slobodan
S
Loga
Svjetlana
S
Loga-Zec
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D015897:Comorbidity; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000453:epidemiology; D011613:Psychotherapy / Q000379:methods; D011618:Psychotic Disorders / Q000188:drug therapy / Q000453:epidemiology; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D011619:Psychotropic Drugs